How big is the Peptide And Oligonucleotide CDMO Market?

The Peptide And Oligonucleotide CDMO Market size is expected to reach USD 2.40 billion in 2024 and grow at a CAGR of 11.70% to reach USD 4.67 billion by 2029. Read More

What is the current Peptide And Oligonucleotide CDMO Market size?

In 2024, the Peptide And Oligonucleotide CDMO Market size is expected to reach USD 2.40 billion. Read More

Who are the key players in Peptide And Oligonucleotide CDMO Market?

Thermo Fisher Scientific Inc., Polypeptide Group, Wuxi Apptec Co., Ltd., Genscript Biotech Corporation and CordenPharma International are the major companies operating in the Peptide And Oligonucleotide CDMO Market. Read More

Which is the fastest growing region in Peptide And Oligonucleotide CDMO Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Peptide And Oligonucleotide CDMO Market?

In 2024, the North America accounts for the largest market share in Peptide And Oligonucleotide CDMO Market. Read More

What years does this Peptide And Oligonucleotide CDMO Market cover, and what was the market size in 2023?

In 2023, the Peptide And Oligonucleotide CDMO Market size was estimated at USD 2.12 billion. The report covers the Peptide And Oligonucleotide CDMO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Peptide And Oligonucleotide CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Peptide And Oligonucleotide CDMO Market Share

Statistics for the 2023 & 2024 Peptide And Oligonucleotide CDMO market share, created by Mordor Intelligence™ Industry Reports. Peptide And Oligonucleotide CDMO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Peptide And Oligonucleotide CDMO Industry

The market for peptide and oligonucleotide contract development and manufacturing organizations is moderately competitive, with both small and large players involved in strategic activities such as the expansion of services, partnerships, collaborations, as well as mergers, and acquisitions. Key players are Thermo Fisher Scientific Inc., Polypeptide Group, Wuxi Apptec Co. Ltd, Genscript Biotech Corporation, and CordenPharma International.